ES8504160A1 - Procedimiento para la preparacion de derivados de propan-2-ol - Google Patents

Procedimiento para la preparacion de derivados de propan-2-ol

Info

Publication number
ES8504160A1
ES8504160A1 ES534479A ES534479A ES8504160A1 ES 8504160 A1 ES8504160 A1 ES 8504160A1 ES 534479 A ES534479 A ES 534479A ES 534479 A ES534479 A ES 534479A ES 8504160 A1 ES8504160 A1 ES 8504160A1
Authority
ES
Spain
Prior art keywords
propan
derivatives
preparation
compounds containing
pharmaceutical compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES534479A
Other languages
English (en)
Other versions
ES534479A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Heumann Ludwig and Co GmbH
Original Assignee
Heumann Ludwig and Co GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heumann Ludwig and Co GmbH filed Critical Heumann Ludwig and Co GmbH
Publication of ES534479A0 publication Critical patent/ES534479A0/es
Publication of ES8504160A1 publication Critical patent/ES8504160A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE DERIVADOS DE PROPAN-2OL.COMPRENDE: A) HACER REACCIONAR UNA PROPAN-2-OLAMINA DE FORMULA (II) CON UN DERIVADO DE TIDIAZOL DE FORMULA (III) O CON UN DERIVADO DE CICLOBUTEDIONA DE FORMULA (IV); PARA OBTENER UN DERIVADO DE PROPAN-2-OL DE FORMULA (V) O (VI); B) HACER A (V) O (VI) UNA SATURACION DE AMONIACO, PARA OBTENER COMPUESTOS DE FORMULA (I) Y SUS SALES FARMACEUTICAMENTE ACEPTABLES; SE EFECTUA EN DISOLVENTES INERTES Y A UNA TEMPERATURA ENTRE LA AMBIENTE Y LA TEMPERATURA DE EBULLICION DEL DISOLVENTE; C) SIENDO R LOS RADICALES DE FORMULA (VI) O (VII).SE UTILIZA COMO INHIBIDORES PARA RECEPTORES -H2 DE HINSTAMINA.
ES534479A 1983-07-22 1984-07-20 Procedimiento para la preparacion de derivados de propan-2-ol Expired ES8504160A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833326545 DE3326545A1 (de) 1983-07-22 1983-07-22 Propan-2-ol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Publications (2)

Publication Number Publication Date
ES534479A0 ES534479A0 (es) 1985-04-16
ES8504160A1 true ES8504160A1 (es) 1985-04-16

Family

ID=6204708

Family Applications (1)

Application Number Title Priority Date Filing Date
ES534479A Expired ES8504160A1 (es) 1983-07-22 1984-07-20 Procedimiento para la preparacion de derivados de propan-2-ol

Country Status (16)

Country Link
US (1) US4599346A (es)
EP (1) EP0132541A3 (es)
JP (1) JPS6042375A (es)
KR (1) KR850001185A (es)
AR (1) AR242380A1 (es)
AU (1) AU560038B2 (es)
DE (1) DE3326545A1 (es)
DK (1) DK290584A (es)
ES (1) ES8504160A1 (es)
GR (1) GR82256B (es)
HU (1) HU192038B (es)
IL (1) IL72179A0 (es)
NZ (1) NZ208968A (es)
PT (1) PT78923B (es)
YU (1) YU123084A (es)
ZA (1) ZA844651B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR033779A1 (es) * 2001-06-08 2004-01-07 Astrazeneca Ab Compuestos utiles en la enfermedad de reflujo
KR20040027404A (ko) 2002-09-25 2004-04-01 다이소 가부시키가이샤 글리시딜프탈이미드의 제조방법
AU2003272967A1 (en) * 2002-10-28 2004-05-13 Kaneka Corporation Processes for producing optically active n-(2,3-epoxypropan-1-yl)phthalimide
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189197C (nl) * 1979-09-04 1993-02-01 Bristol Myers Squibb Co 3,4-digesubstitueerde-1,2,5-thiadiazool-1-oxiden en 1,1-dioxiden, bereiding daarvan alsmede farmaceutische preparaten.
US4390701A (en) * 1981-05-18 1983-06-28 Bristol-Myers Company 1-Amino-2-[3-(3-piperidinomethylphenoxy)propylamino]cyclobutene-3,4-dione
AU8635482A (en) * 1981-07-24 1983-01-27 Glaxo Group Limited Derivatives of amino 1,2,4-triazoles
US4411899A (en) * 1981-12-21 1983-10-25 Merck & Co., Inc. Substituted derivatives of amino alkane diols as gastric secretion inhibitors
GB2124622A (en) * 1982-07-08 1984-02-22 Glaxo Group Ltd Thiadiazole derivatives
FI832520L (fi) * 1982-07-12 1984-01-13 Bristol Myers Co Farmaceutiska foerfaranden och sammansaettningar
US4521625A (en) * 1982-10-02 1985-06-04 Smith Kline & French Laboratories Limited Dioxocyclobutene compounds

Also Published As

Publication number Publication date
EP0132541A3 (de) 1985-09-25
AU560038B2 (en) 1987-03-26
AR242380A1 (es) 1993-03-31
ES534479A0 (es) 1985-04-16
IL72179A0 (en) 1984-10-31
HUT34964A (en) 1985-05-28
NZ208968A (en) 1986-11-12
DK290584A (da) 1985-01-23
US4599346A (en) 1986-07-08
ZA844651B (en) 1986-02-26
YU123084A (en) 1986-10-31
HU192038B (en) 1987-04-28
AU2953684A (en) 1985-01-24
PT78923A (de) 1984-08-01
KR850001185A (ko) 1985-03-16
DE3326545A1 (de) 1985-01-31
EP0132541A2 (de) 1985-02-13
GR82256B (es) 1984-12-13
DK290584D0 (da) 1984-06-13
PT78923B (de) 1986-06-02
JPS6042375A (ja) 1985-03-06

Similar Documents

Publication Publication Date Title
DE3167320D1 (en) Novel uracil derivatives, process for preparing the same and a pharmaceutical composition containing the same
ES8304563A1 (es) Procedimiento para la preparacion de derivados de isoquino- leina
ES8401944A1 (es) Procedimiento para la preparacion de derivados de acido salicilico.
ES8502440A1 (es) Procedimiento para preparar acepinoindoles.
DE3483308D1 (de) Semicarbazid-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ZA836663B (en) Isoquinoline derivatives,a process for their preparation,pharmaceutical formulations based on these compounds and the use thereof
CA2094122A1 (fr) Procede de preparation par compression directe de comprimes de derives de l'acide cephalosporanique
ES8401940A1 (es) Procedimiento para la preparacion de derivados de oxindol.
ES8504160A1 (es) Procedimiento para la preparacion de derivados de propan-2-ol
PT78870B (en) Process for preparing novel pharmaceutical compounds based on benzyl fenyl derivatives
IE873212L (en) Medicaments based on derivatives of 3,4-di-phenylpiperidine,¹the use of the derivatives as medicaments, and novel¹3,4-diphenylpiperidine derivatives and a process for the¹preparation therefor
DE3378120D1 (en) Thiazaspiro derivatives, process for their preparation and pharmaceutical composition
HUT56498A (en) Process for producing pharmaceutical compositions having antiviral effect, containing benzylphosphonic acid derivatives
ES8700245A1 (es) Procedimiento para la preparacion de derivados de 1,3,4-tia-diazol
ES8305734A1 (es) "procedimiento para la preparacion de derivados de 5(6)-fenil-sulfoniloxi-bencimidazol".
ES8609315A1 (es) Procedimiento para preparar derivados de 3,4 diazol
JPS52136165A (en) Purification of pyrrolidine derivatives
ES8301933A1 (es) "procedimiento para la preparacion de derivados de 4-(5)-alcohil-mercaptoimidazoles".
IT8323425A0 (it) Epinina 3-0- e 4-0-solfato, loro sali, procedimenti per prepararli e forme farmaceutiche che licontengono.
NO910056L (no) Fremgangsmaate for fremstilling av 2,6-substituert-3,5-pyridindicarboxylsyrederivater.
NO910055L (no) Fremgangsmaate for fremstilling av 2,6-substituert-3,5-pyridindicarboxylsyrederivater.
NO910054L (no) Fremgangsmaate for fremstilling av 2,6-substituert-3,5-pyridindicarboxylsyrederivater.
NO910057L (no) Fremgangsmaate for fremstilling av 2,6-substituert-3,5-pyridindicarboxylsyrederivater.